Adolescents with type 1 diabetes may be at elevated risk for somatic problems. This study used cross-sectional, baseline data from an intervention to examine if problems with executive function (EF) were associated with greater somatic problems independent of poor adherence and disease severity in adolescents with type 1 diabetes and above target glycemic control. In addition, it examined whether certain types of EF skills, that is, metacognitive and behavior regulation, accounted for variance in somatic problems. Ninety-three adolescents completed a glycated hemoglobin (HbA1c) blood test and parents completed adherence, somatic problems, and EF questionnaires, which measured metacognitive, behavior regulation, and global EF. Greater somatic problems had significant bivariate associations with greater global (r = 0.42, P < 0.01), metacognitive (r = 0.43, P < 0.01), and behavior regulation EF problems (r = 0.31, P < 0.01), worse adherence (r = −0.39, P < 0.01), and poorer metabolic control (r = 0.26, P < 0.05). However, when adherence, metabolic control, and EF subscales were examined together in the same model, only greater global EF problems (b = 0.15, P < 0.01) and metacognitive EF problems (b = 0.16, P < 0.01) were independently associated with greater somatic problems; behavior regulation EF problems were not independently associated with greater somatic problems when controlling for adherence. Metacognitive EF problems may predict somatic problems in adolescents with above target glycemic control above and beyond physical symptoms related to disease management, underscoring the importance of proper assessment and treatment of these distinct somatic problems.
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| INTRODUCTION
Somatic problems are perceived physical ailments (eg, aches, pains, nausea, and vision problems) that may or may not be explained by an identifiable physical illness, and these problems predict worse healthrelated quality of life (HRQoL) across numerous chronic diseases and conditions. 1, 2 In addition, somatic problems are associated with high utilization of and high expenditures for medical services, with
researching showing average healthcare costs of patients with somatic problems to be as much as 14 times higher than those of average patients. 3 Youths with type 1 diabetes have been shown to be at greater risk for somatic problems than youth without type 1 diabetes, [4] [5] [6] but the mechanism through which this increased risk occurs remains unclear.
Type 1 diabetes is a chronic autoimmune disease that destroys cells in the pancreas that produce insulin-a hormone that converts blood sugar into energy. Individuals with type 1 diabetes must adhere to an intensive daily medical regimen to maintain healthy glucose levels. In adolescents with type 1 diabetes, increased somatic problems have been associated with worse disease severity (ie, poorer metabolic control) in at least one study. 5 An explanation for this finding is that poor adherence leads to increased disease severity, which exacerbates physical symptoms associated with type 1 diabetes, causing increased somatic problems. However, research in other chronic illness populations 7, 8 has suggested that not only disease severity, but also problems with executive function, may contribute to increased somatic problems, possibly through decreasing one's ability to appropriately interpret and cope with bodily signals. 16, 17 implying that perseveration on a physical symptom (eg, stomach pain) may be a pathway through which executive function deficits contribute to somatic problems. Board. There is no missing data to report.
| Procedures
Intake assessments were conducted in the pediatric endocrinology department or a study office centrally located in the region. The study was explained to parents/guardians and adolescents, and parental/ guardian consent and adolescent assent were obtained for all participants. Both the adolescent and parents completed a series of tasks and/or questionnaires. In this study, we used parent-reported youth somatic problems, parent-reported youth executive function, parentreported adherence, and a glycosylated hemoglobin blood test for the youth.
| Measures 2.3.1 | Child behavior checklist -DSM-oriented somatic problems subscale
The child behavior checklist (CBCL) 22 is a parent-report measure used to identify behavioral and emotional problems across eight empirically derived syndrome scales and six Diagnostic and Statistical Manual of Mental Disorders (DSM)-oriented scales, including somatic problems.
The DSM-oriented scales were created by asking experienced and culturally diverse child psychiatrists and psychologists to rate how consistent CBCL items were with specific DSM diagnostic categories.
Items rated as very consistent by at least 64% of the raters were included in the DSM-oriented scales. The DSM-oriented somatic problems subscale was selected for use in this study to index somatic problems as traditionally classified in the DSM that have been previously linked to clinically important outcomes of diminished HRQoL. 4, 23, 24 The DSM-oriented subscale excludes items from the CBCL somatic complaints syndrome subscale less relevant to disease burden and HRQoL (eg, nightmares). The DSM-oriented somatic problems subscale includes 7 items to assess somatization: aches and pains, headaches, nausea, eye problems, rashes and skin problems, stomachaches, and vomiting. The CBCL previously has been used to measure behavioral, somatic, and emotional problems in youth with type 1 diabetes. The use of parent-reported adherence in the context of this study was supported by evidence to suggest parent-and youth-reported adherence are differentially linked with overall diabetes management and HbA1c. 35 Specifically, youth reports of adherence have been found to correlate closely with one element of adherence, frequency of daily self-monitoring of blood glucose, but less so with HbA1c, whereas primary caregiver reports of adherence correlate more closely with HbA1c across time, potentially representing a more comprehensive assessment of overall diabetes management. 35 This discrepancy informed the decision to use parent-reported adherence in the context of this study, as opposed to an average or a latent variable that combined parent-and youth-report, which may have obscured important variability in predicting HbA1c.
| Metabolic control
HbA1c from a blood sample at study intake was used as the measure of metabolic control. Because these data are combined from two iterations of the same intervention, HbA1c was measured through a venous blood test for 76 youth (with all samples analyzed in the same central laboratory), and a point of care glycosylated hemoglobin blood test was conducted for 17 youth. HbA1c serves as an indicator of metabolic control over the previous 3 months. Table 1 for somatic problems, adherence, HbA1c, GEC, BRI, and MI. Greater somatic problems were associated with greater executive function problems on the GEC, BRI, and MI indices (see Table 1 ). In addition, greater somatic problems, the GEC, and the BRI were significantly associated with higher (worse) HbA1c; however, MI was not associated with HbA1c. Parent-reported adherence was associated with HbA1c, somatic problems, and greater executive function problems on all three subscales (ie, the GEC, BRI, and MI indices). This suggests that executive function, adherence, and HbA1c were all linked with somatic problems.
| Analyses
To examine the association between executive function and somatic problems while accounting for the relation between somatic problems and both adherence and HbA1c, multiple linear regressions were conducted. In Step 1, pump status, but not duration of disease or type of HbA1c test, was significantly associated with somatic problems. In Step 2, HbA1c, but not pump status, duration of disease, or type of HbA1c test, was significantly correlated with somatic problems. In Step 3, adherence was added to the model and only adherence, but none of the other predictors, including HbA1c, was significantly correlated with somatic problems. In Step 4, three different models were examined, first using the GEC as a predictor, then the BRI, and last the MI. In the model with the GEC added in Step 4 (see Table 2 ), the full model was significant. Higher scores on the GEC, indicating greater problems with executive function, were significantly associated with somatic problems and accounted for 22% more variance explained in somatic problems. In addition, worse adherence, but not HbA1c, was still associated with somatic problems after controlling for GEC. Next, in the model with BRI added in Step 4 (see Table 2 ), the full model was significant. Worse adherence remained statistically significantly associated with somatic problems after controlling for BRI, but higher scores on BRI were not statistically significantly associated with greater somatic problems, despite accounting for 17% more variance explained in somatic problems.
Finally, in the model with MI added in Step 4 (see Table 2 ), the full model was significant, and higher scores on MI were associated with greater somatic problems, accounting for 24% more variance explained in somatic problems.
In addition, we conducted exploratory post-hoc analyses to assess whether any specific subscales within the MI index were more associated with somatic problems than were others, finding that no one subscale of MI independently accounted for the relationship between MI and somatic problems; rather, shared variance across the subscales explained the relation.
In summary, in all Step 4 models, HbA1c was not a significant predictor of somatic problems after controlling for adherence and executive functions. Although adherence remained a significant predictor of somatic problems in each Step 4 model, the GEC and MI executive function subscales were associated with somatic problems Abbreviations: BRI, Behavior Regulation Index; GEC, Global Executive Composite; MI, Metacognition Index; SCI, self-care inventory. *P < 0.05, **P < 0.01, ***P < 0.001.
independent of the link between adherence and somatic problems.
This finding supports the hypothesis that executive function and specifically metacognitive executive function problems would be associated with somatic problems independent of both HbA1c and adherence. Abbreviations: BRI, Behavior Regulation Index; GEC, Global Executive Composite; MI, Metacognition Index. *P < 0.05, **P < 0.01, ***P < 0.001. a Steps 1, 2, and 3 were the same for all three models, with Step 4 adding each executive function variable individually into the model. function, and metacognitive executive function in particular, may result in ruminative thoughts, catastrophizing, and cognitive inflexibility, which may uniquely contribute to somatic problems in adolescents with type 1 diabetes and above target glycemic control.
| DISCUSSION
An interesting finding from this study is that adherence predicted somatic problems above and beyond metabolic control. Thus, it may be that non-adherence contributed more to momentary or day-to-day type 1 diabetes symptoms that are not reflected in average HbA1c, thereby capturing more variance in the somatic problems that may be related to the disease process. Nevertheless, despite the relation between non-adherence and somatic problems, executive function predicted variance in somatic problems uniquely from adherence, suggesting problems with executive function are related to somatic problems through a different pathway.
This unique pathway between problems with executive function and somatic problems was elucidated in part through our investigation into which subtype of executive function was most associated with somatic problems. The results indicated that deficits in metacognitive executive function remained a robust predictor of somatic problems even after controlling for metabolic control and adherence, whereas deficits in behavioral regulation executive function failed to be a significant predictor of somatic problems after controlling for adherence.
This is consistent with other literature finding an association between deficits in metacognition or metacognitive executive skills and somatic problems. 18, 37 More specifically, this finding supports that difficulties with metacognitive executive function, such as heightened focus on threatening stimuli, perseverative thinking, and inability to shift attention away from these thoughts, may be related to fixation and rumination on, as well as catastrophizing of physical symptoms, contributing to somatic problems. 18 For example, problems with metacognitive executive function, such as excessive worrying about a physical symptom, may serve to strengthen and perpetuate health-related concerns through prolonged activation and reinforcement of cognitive pathways related to the somatic problems. 38 Brosschot and Thayer 38 These findings should be interpreted in the context of some limitations. White adolescents made up the majority of this sample. As such, these findings may not generalize to racial or ethnic minority adolescents, and replication in a larger, more diverse sample is needed.
Also, given that the sample consisted of adolescents with above target glycemic control (HbA1c ≥ 8 or 64 mmol/mol), the restriction of HbA1c range may have reduced our ability to see a greater association of HbA1c with somatic problems and executive function and limited the generalizability of these findings. In addition, we recognize that those with higher HbA1c may present with more physical problems as a result of poor metabolic control; nevertheless, the purpose of this study was to examine how physical symptoms may exist in excess of poor adherence or HbA1c level, that is, there may be other contributing factors to consider, such as poor executive function and its relation to somatic problems.
In addition, analyses were limited to cross-sectional hypotheses due to the nature of the clinical trial following this data collection. Finally, apart from HbA1c, the other measures-executive function, adherence, and somatic problems-were parent reported. This is particularly relevant to somatic problems, as some investigators have suggested that parents conflate physiologic symptoms associated with above target glycemic control and somatic problems (or physical symptoms "without medical cause") when reporting on adolescents' somatic problems. 13 However, research has indicated that physiological items relevant to diabetes (eg, dizziness and headaches) captured by the CBCL somatic subscales do not artificially inflate somatic problem scores of youth with type 1 diabetes. 11 Nevertheless, additional research utilizing teen, parent, and health care provider reports as well Given that somatic problems are associated with worse HRQoL at the individual level 1,2 and exorbitant health care costs and utilization at the societal level, 43 these findings are clinically and practically significant. There is preliminary evidence suggesting metacognitive therapy may reduce somatic problems through attention training, for example, diverting attention from heightened threat monitoring. 18, 44, 45 Furthermore, there is evidence to support that among youth with executive function deficits, executive function training focused on metacognitive executive skills has resulted in substantial gains in executive function generally, in the BRIEF-measured MI specifically, and in youths' overall ability to regulate thoughts. 46 Thus, when a pediatric endocrinologist sees a patient with type 1 diabetes exhibiting significant physical symptoms that are not consistent with the patients' level of adherence or disease severity, it is worth considering that these symptoms may be somatic problems related to problems with metacognitive executive function. These types of encounters represent key moments to assess for somatic complaints or refer patients to psychosocial services that may be able to better identify and target executive function and somatic problems through the treatments described above, whereas more traditional medical treatments addressing changes in metabolic control or adherence may be insufficient. While such interventions may not necessarily improve HbA1c-given that metacognitive executive function skills and HbA1c
were not associated in this sample-they may help adolescents with comorbid type 1 diabetes and somatic problems increase adherence, but perhaps equally importantly, reduce somatic problems and their associated health care costs and health care utilization. Thus, for those adolescents struggling with both above target glycemic control and somatic problems, there are accessible methods available that may boost their metacognitive executive skills, lessen their somatic problems, and ultimately improve their HRQoL.
